Satre Derek D, Mertens Jennifer R, Areán Patricia A, Weisner Constance
Department of Psychiatry, University of California, San Francisco 94143, USA.
Addiction. 2004 Oct;99(10):1286-97. doi: 10.1111/j.1360-0443.2004.00831.x.
This study compared 5-year treatment outcomes of older adults to those of middle-aged and younger adults in a large managed care chemical dependency program. We examined age group differences in individual, treatment and extra-treatment factors, which may influence long-term outcome.
Seventy-seven per cent of original study participants completed a telephone interview 5 years after out-patient chemical dependency treatment at Kaiser Permanente. This sample (N = 925) included 65 patients aged 55-77, 296 patients aged 40-54 and 564 patients aged 18-39 (age at baseline).
Measures at follow-up included alcohol and drug use, Addiction Severity Index (ASI), Alcoholics Anonymous Affiliation Scale, social resource and self-reported health questions. Mortality data were obtained from contact with family members of patients as well as automated health plan records.
Older adults were less likely to be drug-dependent at baseline than younger and middle-aged adults, and had longer retention in treatment than younger adults. At 5 years, older adults were less likely than younger adults to have close family or friends who encouraged alcohol or drug use. Fifty-two per cent of older adults reported total abstinence from alcohol and drugs in the previous 30 days versus 40% of younger adults. Older women had higher 30-day abstinence than older men or younger women. Among participants dependent only on alcohol, there were no significant age differences in 30-day abstinence. In logistic regression analysis, age group was not significant. Variables associated with greater age that independently predicted 30-day abstinence in the logistic regression model included longer retention in treatment and having no close family or friends who encouraged alcohol or drug use at 5 years; female gender was also significant.
Results indicate that older adults have favorable long-term outcome following treatment relative to younger adults, but these differences may be accounted for by variables associated with age such as type of substance dependence, treatment retention, social networks and gender. Age differences in these characteristics inform intervention strategies to support long-term recovery of older adults and provide direction for investigation of how age affects outcome.
本研究在一个大型管理式医疗化学物质依赖项目中,比较了老年人与中青年成年人的5年治疗结果。我们研究了个体、治疗及治疗外因素在年龄组间的差异,这些因素可能会影响长期治疗结果。
原研究参与者中有77%在凯撒医疗集团接受门诊化学物质依赖治疗5年后完成了电话访谈。该样本(N = 925)包括65名年龄在55 - 77岁的患者、296名年龄在40 - 54岁的患者以及564名年龄在18 - 39岁的患者(基线年龄)。
随访测量指标包括酒精和药物使用情况、成瘾严重程度指数(ASI)、匿名戒酒会参与量表、社会资源以及自我报告的健康问题。死亡数据通过与患者家属联系以及自动化健康计划记录获得。
与中青年成年人相比,老年人在基线时药物依赖的可能性较小,且在治疗中的留存时间比年轻人更长。在5年时,与年轻人相比,老年人拥有鼓励饮酒或吸毒的亲密家人或朋友的可能性较小。52%的老年人报告在过去30天内完全戒酒戒毒,而年轻人中这一比例为40%。老年女性的30天戒酒戒毒率高于老年男性或年轻女性。在仅依赖酒精的参与者中,30天戒酒率在年龄上没有显著差异。在逻辑回归分析中,年龄组不显著。在逻辑回归模型中,与年龄较大独立预测30天戒酒戒毒相关的变量包括在治疗中的留存时间更长以及在5年时没有鼓励饮酒或吸毒的亲密家人或朋友;女性性别也具有显著性。
结果表明,相对于年轻人,老年人治疗后的长期结果较好,但这些差异可能由与年龄相关的变量所解释,如物质依赖类型、治疗留存、社会网络和性别。这些特征在年龄上的差异为支持老年人长期康复的干预策略提供了依据,并为研究年龄如何影响治疗结果提供了方向。